𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biowaiver monographs for immediate release solid oral dosage forms: Prednisone

✍ Scribed by M. Vogt; H. Derendorf; J. Krämer; H.E. Junginger; K.K. Midha; V.P. Shah; S. Stavchansky; J.B. Dressman; D.M. Barends

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
140 KB
Volume
96
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing prednisone are reviewed. Due to insufficient data prednisone cannot be definitively classified according to the current Biopharmaceutics Classification System (BCS) criteria as both the solubility and the permeability of prednisone are on the borderline of the present criteria of BCS Class I. Prednisone's therapeutic indications and therapeutic index, pharmacokinetics and the possibility of excipient interactions were also taken into consideration. Available evidence indicates that a biowaiver for IR solid oral dosage forms formulated with the excipients tabulated in this article would be unlikely to expose patients to undue risks.

📜 SIMILAR VOLUMES

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin
✍ C. Becker; J.B. Dressman; H.E. Junginger; S. Kopp; K.K. Midha; V.P. Shah; S. Sta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing rifampicin as the only Active Pharmaceutical Ingredient (API) are reviewed. Rifampicin's so

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen
✍ H. Potthast; J.B. Dressman; H.E. Junginger; K.K. Midha; H. Oeser; V.P. Shah; H. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Literature data are reviewed on the properties of ibuprofen related to the biopharmaceutics classification system (BCS). Ibuprofen was assessed to be a BCS class II drug. Differences in composition and/or manufacturing procedures were reported to have an effect on the rate, but not the extent of abs

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Isoniazid
✍ C. Becker; J.B. Dressman; G.L. Amidon; H.E. Junginger; S. Kopp; K.K. Midha; V.P. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing isoniazid as the only active pharmaceutical ingredient (API) are reviewed. Isoniazid's solubility and permeability character